The Cell Reprogramming Market, valued at USD 374.2 million in 2022, is poised for significant growth over the next several years. By 2030, the market is expected to reach USD 720.2 million, expanding at a compound annual growth rate (CAGR) of 8.53% from 2023 to 2030. Cell reprogramming technologies, which involve converting specialized cells into pluripotent stem cells or other cell...